[Ref.: #11592] |
Culture collection no. |
DSM 44196, ATCC 19977, CCUG 20993, CIP 104536, JCM 13569, NCTC 13031, TMC 1543, Hauduroy L948, CCUG 27982, DSM 43491 |
[Ref.: #77815] |
SI-ID 92877
|
* |
|
Literature: |
Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries. |
|
Topic |
Title |
Authors |
Journal |
DOI |
Year |
|
Metabolism |
Transposon mutagenesis in Mycobacterium abscessus identifies an essential penicillin-binding protein involved in septal peptidoglycan synthesis and antibiotic sensitivity. |
Akusobi C, Benghomari BS, Zhu J, Wolf ID, Singhvi S, Dulberger CL, Ioerger TR, Rubin EJ |
Elife |
10.7554/eLife.71947 |
2022 |
* |
Pathogenicity |
Rapid and Accurate Differentiation of Mycobacteroides abscessus Complex Species by Liquid Chromatography-Ultra-High-Resolution Orbitrap Mass Spectrometry. |
Bajaj AO, Slechta ES, Barker AP |
Front Cell Infect Microbiol |
10.3389/fcimb.2022.809348 |
2022 |
* |
Pathogenicity |
Comparison of Isogenic Strains Shows No Evidence of Altered Nosocomial Transmission-Competency of Rough, GPL-Negative Mycobacterium abscessus Strains. |
Meir M, Foreman M, Bar-Oz M, Naor N, Rozenblit A, Barkan D |
Microbiol Spectr |
10.1128/spectrum.01990-21 |
2022 |
* |
Pathogenicity |
Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. |
Sudadech P, Roytrakul S, Kaewprasert O, Sirichoat A, Chetchotisakd P, Kanthawong S, Faksri K |
PLoS One |
10.1371/journal.pone.0260003 |
2021 |
* |
Pathogenicity |
RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus. |
Schildkraut JA, Coolen JPM, Burbaud S, Sangen JJN, Kwint MP, Floto RA, Op den Camp HJM, Te Brake LHM, Wertheim HFL, Neveling K, Hoefsloot W, van Ingen J |
Antimicrob Agents Chemother |
10.1128/AAC.01509-21 |
2021 |
* |
Genetics |
Genome-Wide Essentiality Analysis of Mycobacterium abscessus by Saturated Transposon Mutagenesis and Deep Sequencing. |
Rifat D, Chen L, Kreiswirth BN, Nuermberger EL |
mBio |
10.1128/mBio.01049-21 |
2021 |
* |
Pathogenicity |
Secretome characterization of clinical isolates from the Mycobacterium abscessus complex provides insight into antigenic differences. |
Cornejo-Granados F, Kohl TA, Sotomayor FV, Andres S, Hernandez-Pando R, Hurtado-Ramirez JM, Utpatel C, Niemann S, Maurer FP, Ochoa-Leyva A |
BMC Genomics |
10.1186/s12864-021-07670-7 |
2021 |
* |
Genetics |
Genome Sequence of Mycobacterium abscessus Phage phiT45-1. |
Amarh ED, Gauthier CH, Dedrick RM, Garlena RA, Russell DA, Jacobs-Sera D, Zack KM, Hatfull GF |
Microbiol Resour Announc |
10.1128/MRA.00155-21 |
2021 |
* |
Stress |
Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus. |
Ng HF, Ngeow YF, Yap SF, Zin T, Tan JL |
Int J Med Microbiol |
10.1016/j.ijmm.2019.151380 |
2019 |
* |
Phylogeny |
Mycobacterium abscessus infection in the stomach of patients with various gastric symptoms. |
Chouhan D, Barani Devi T, Chattopadhyay S, Dharmaseelan S, Nair GB, Devadas K, Radhakrishna Pillai M |
PLoS Negl Trop Dis |
10.1371/journal.pntd.0007799 |
2019 |
* |
Pathogenicity |
Inhibition of Mycobacterium abscessus, M. chelonae, and M. fortuitum biofilms by Methylobacterium sp. |
Garcia-Coca M, Rodriguez-Sevilla G, Perez-Domingo A, Aguilera-Correa JJ, Esteban J, Munoz-Egea MC |
J Antibiot (Tokyo) |
10.1038/s41429-019-0232-6 |
2019 |
* |
Pathogenicity |
The differential effect of clarithromycin and azithromycin on induction of macrolide resistance in Mycobacterium abscessus. |
Schildkraut JA, Pennings LJ, Ruth MM, de Brouwer AP, Wertheim HF, Hoefsloot W, de Jong A, van Ingen J |
Future Microbiol |
10.2217/fmb-2018-0310 |
2019 |
* |
Enzymology |
Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus. |
Ruth MM, van Rossum M, Koeken VACM, Pennings LJ, Svensson EM, Ruesen C, Bowles EC, Wertheim HFL, Hoefsloot W, van Ingen J |
Antimicrob Agents Chemother |
10.1128/AAC.00449-19 |
2019 |
* |
Phylogeny |
Antimicrobial properties of basidiomycota macrofungi to Mycobacterium abscessus isolated from patients with cystic fibrosis. |
Millar BC, Nelson D, Moore RE, Rao JR, Moore JE |
Int J Mycobacteriol |
10.4103/ijmy.ijmy_167_18 |
2019 |
* |
Pathogenicity |
Dual beta-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro. |
Pandey R, Chen L, Manca C, Jenkins S, Glaser L, Vinnard C, Stone G, Lee J, Mathema B, Nuermberger EL, Bonomo RA, Kreiswirth BN |
mBio |
10.1128/mBio.02895-18 |
2019 |
* |
Pathogenicity |
In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex. |
Cheng A, Tsai YT, Chang SY, Sun HY, Wu UI, Sheng WH, Chen YC, Chang SC |
Antimicrob Agents Chemother |
10.1128/AAC.02234-18 |
2019 |
* |
Pathogenicity |
A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. |
Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J |
J Antimicrob Chemother |
10.1093/jac/dky526 |
2019 |
* |
Pathogenicity |
Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus. |
Kirkwood ZI, Millar BC, Downey DG, Moore JE |
Int J Mycobacteriol |
10.4103/ijmy.ijmy_142_18 |
2018 |
* |
Phylogeny |
A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex. |
Steindor M, Nkwouano V, Stefanski A, Stuehler K, Ioerger TR, Bogumil D, Jacobsen M, Mackenzie CR, Kalscheuer R |
Microbes Infect |
10.1016/j.micinf.2018.10.006 |
2018 |
* |
Genetics |
A mutation in anti-sigma factor MAB_3542c may be responsible for tigecycline resistance in Mycobacterium abscessus. |
Ng HF, Tan JL, Zin T, Yap SF, Ngeow YF |
J Med Microbiol |
10.1099/jmm.0.000857 |
2018 |
* |
Pathogenicity |
Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against Mycobacterium abscessus: Implication for patients with cystic fibrosis. |
Moore JE, Koulianos G, Hardy M, Misawa N, Millar BC |
Int J Mycobacteriol |
10.4103/ijmy.ijmy_73_18 |
2018 |
* |
Pathogenicity |
In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus. |
Le Run E, Arthur M, Mainardi JL |
Antimicrob Agents Chemother |
10.1128/AAC.00623-18 |
2018 |
* |
Pathogenicity |
Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus. |
Ramis IB, Figueiredo R, Ramos DF, Halicki PCB, von Groll A, Viveiros M, do Ceu Costa M, da Silva PEA |
Med Chem |
10.2174/1573406414666171204102633 |
2018 |
* |
Pathogenicity |
Antibiofilm activity of nanoemulsions of Cymbopogon flexuosus against rapidly growing mycobacteria. |
Rossi GG, Guterres KB, Bonez PC, da Silva Gundel S, Aggertt VA, Siqueira FS, Ourique AF, Wagnerd R, Klein B, Santos RCV, de Campos MMA |
Microb Pathog |
10.1016/j.micpath.2017.11.002 |
2017 |
* |
Pathogenicity |
In Vitro Evaluation of Povidone-Iodine and Chlorhexidine against Outbreak and Nonoutbreak Strains of Mycobacterium abscessus Using Standard Quantitative Suspension and Carrier Testing. |
Cheng A, Sun HY, Tsai YT, Wu UI, Chuang YC, Wang JT, Sheng WH, Hsueh PR, Chen YC, Chang SC |
Antimicrob Agents Chemother |
10.1128/AAC.01364-17 |
2017 |
* |
Metabolism |
Effect of beta-lactamase production and beta-lactam instability on MIC testing results for Mycobacterium abscessus. |
Rominski A, Schulthess B, Muller DM, Keller PM, Sander P |
J Antimicrob Chemother |
10.1093/jac/dkx284 |
2017 |
* |
Pathogenicity |
Increased survival and proliferation of the epidemic strain Mycobacterium abscessus subsp. massiliense CRM0019 in alveolar epithelial cells. |
Ribeiro GM, Matsumoto CK, Real F, Teixeira D, Duarte RS, Mortara RA, Leao SC, de Souza Carvalho-Wodarz C |
BMC Microbiol |
10.1186/s12866-017-1102-7 |
2017 |
* |
Pathogenicity |
Rifabutin Is Active against Mycobacterium abscessus Complex. |
Aziz DB, Low JL, Wu ML, Gengenbacher M, Teo JWP, Dartois V, Dick T |
Antimicrob Agents Chemother |
10.1128/AAC.00155-17 |
2017 |
* |
Enzymology |
Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591. |
Rominski A, Roditscheff A, Selchow P, Bottger EC, Sander P |
J Antimicrob Chemother |
10.1093/jac/dkw466 |
2016 |
* |
Pathogenicity |
Identification of antimicrobial activity among new sulfonamide metal complexes for combating rapidly growing mycobacteria. |
Agertt VA, Bonez PC, Rossi GG, Flores Vda C, Siqueira Fdos S, Mizdal CR, Marques LL, de Oliveira GN, de Campos MM |
Biometals |
10.1007/s10534-016-9951-3 |
2016 |
* |
Pathogenicity |
Bactericidal and intracellular activity of beta-lactams against Mycobacterium abscessus. |
Lefebvre AL, Dubee V, Cortes M, Dorchene D, Arthur M, Mainardi JL |
J Antimicrob Chemother |
10.1093/jac/dkw022 |
2016 |
* |
Pathogenicity |
Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. |
Abdalla MY, Switzer BL, Goss CH, Aitken ML, Singh PK, Britigan BE |
Antimicrob Agents Chemother |
10.1128/AAC.00331-15 |
2015 |
* |
Genetics |
Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. |
Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash K, Parodi N, Strong A, Gee M, Smith T, Wallace RJ Jr |
J Clin Microbiol |
10.1128/JCM.02950-14 |
2015 |
* |
Metabolism |
Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria. |
Maurer FP, Bruderer VL, Castelberg C, Ritter C, Scherbakov D, Bloemberg GV, Bottger EC |
J Antimicrob Chemother |
10.1093/jac/dku550 |
2015 |
* |
Genetics |
Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strains. |
Davidson RM, Hasan NA, Reynolds PR, Totten S, Garcia B, Levin A, Ramamoorthy P, Heifets L, Daley CL, Strong M |
J Clin Microbiol |
10.1128/JCM.01144-14 |
2014 |
* |
Phylogeny |
A phylogenomic approach to bacterial subspecies classification: proof of concept in Mycobacterium abscessus. |
Tan JL, Khang TF, Ngeow YF, Choo SW |
BMC Genomics |
10.1186/1471-2164-14-879 |
2013 |
* |
Pathogenicity |
Bacterial adherence to different meshes used in abdominal surgery. |
Perez-Tanoira R, Isea-Pena MC, Celdran A, Garcia-Vasquez C, Esteban J |
Surg Infect (Larchmt) |
10.1089/sur.2013.032 |
2013 |
* |
Enzymology |
Characterization of broad-spectrum Mycobacterium abscessus class A beta-lactamase. |
Soroka D, Dubee V, Soulier-Escrihuela O, Cuinet G, Hugonnet JE, Gutmann L, Mainardi JL, Arthur M |
J Antimicrob Chemother |
10.1093/jac/dkt410 |
2013 |
* |
Metabolism |
Insertion site and distribution of a genomic island conferring DNA phosphorothioation in the Mycobacterium abscessus complex. |
Howard ST, Newman KL, McNulty S, Brown-Elliott BA, Vasireddy R, Bridge L, Wallace RJ |
Microbiology (Reading) |
10.1099/mic.0.070318-0 |
2013 |
* |
Pathogenicity |
New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. |
Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville P, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM |
J Clin Microbiol |
10.1128/JCM.01132-13 |
2013 |
* |
Genetics |
Mycobacterium abscessus multispacer sequence typing. |
Sassi M, Ben Kahla I, Drancourt M |
BMC Microbiol |
10.1186/1471-2180-13-3 |
2013 |
* |
Cultivation |
Comparative study with two different enrichments in the culture media used in the disinfectant efficacy assay. |
Sabagh BP, Souto Ada S, Reis LM, Silva SA, Pereira DC, Neves Mde C, Pinheiro RR, Duarte RS, Miyazaki NH, Boas MH |
J Microbiol Methods |
10.1016/j.mimet.2011.12.004 |
2011 |
* |
Transcriptome |
Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. |
Macheras E, Roux AL, Bastian S, Leao SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rusch-Gerdes S, Pfyffer G, Bodmer T, Cambau E, Gaillard JL, Heym B |
J Clin Microbiol |
10.1128/JCM.01274-10 |
2010 |
* |
Enzymology |
Diversity of pulsed-field gel electrophoresis patterns of Mycobacterium abscessus type 2 clinical isolates. |
Matsumoto CK, Chimara E, Bombarda S, Duarte RS, Leao SC |
J Clin Microbiol |
10.1128/JCM.01665-10 |
2010 |
* |
Metabolism |
Comparative analysis of immune responses to Mycobacterium abscessus infection and its antigens in two murine models. |
Jeon BY, Kwak J, Lee SS, Cho S, Won CJ, Kim JM, Shin SJ |
J Microbiol |
10.1007/s12275-009-0139-1 |
2009 |
* |
Metabolism |
Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. |
Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, Macheras E, Heym B, Herrmann JL, Daffe M, Brosch R, Risler JL, Gaillard JL |
PLoS One |
10.1371/journal.pone.0005660 |
2009 |
* |
Genetics |
Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae. |
Ripoll F, Deshayes C, Pasek S, Laval F, Beretti JL, Biet F, Risler JL, Daffe M, Etienne G, Gaillard JL, Reyrat JM |
BMC Genomics |
10.1186/1471-2164-8-114 |
2007 |
* |
Enzymology |
Multicenter evaluation of mycobacteria identification by PCR restriction enzyme analysis in laboratories from Latin America and the Caribbean. |
Leao SC, Bernardelli A, Cataldi A, Zumarraga M, Robledo J, Realpe T, Mejia GI, da Silva Telles MA, Chimara E, Velazco M, Fernandez J, Rodrigues PA, Guerrero MI, Leon CI, Porras TB, Rastogi N, Goh KS, Suffys P, da Silva Rocha A, dos Santos Netto D, Ritacco V, Lopez B, Barrera L, Palomino JC, Martin A, Portaels F |
J Microbiol Methods |
10.1016/j.mimet.2004.11.015 |
2004 |
* |
Enzymology |
Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation. |
Zhang Y, Yakrus MA, Graviss EA, Williams-Bouyer N, Turenne C, Kabani A, Wallace RJ Jr |
J Clin Microbiol |
10.1128/JCM.42.12.5582-5587.2004 |
2004 |
* |
Pathogenicity |
[Investigation of drug-resistance to rifampin and rpoB gene sequence analysis of Mycobacterium abscessus]. |
Sha W, Weng XH, Xiao HP, He GJ |
Zhonghua Jie He He Hu Xi Za Zhi |
|
2003 |
* |
Pathogenicity |
A polymorphic region in Mycobacterium abscessus contains a novel insertion sequence element. |
Howard ST, Byrd TF, Lyons CR |
Microbiology (Reading) |
10.1099/00221287-148-10-2987 |
2002 |
* |
Enzymology |
DNA polymorphism of Mycobacterium abscessus analyzed by infrequent-restriction-site polymerase chain reaction. |
Su LH, Chia JH, Leu HS, Cheng SW, Kuo AJ, Sun CF, Wu TL |
Chang Gung Med J |
|
2000 |
* |
Phylogeny |
Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. |
Kusunoki S, Ezaki T |
Int J Syst Bacteriol |
10.1099/00207713-42-2-240 |
1992 |
* |
|
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus. |
Bich Hanh BT, Quang NT, Park Y, Heo BE, Jeon S, Park JW, Jang J |
Front Pharmacol |
10.3389/fphar.2021.790767 |
2021 |
* |
|
Photo-damage promoted by tetra-cationic palladium(II) porphyrins in rapidly growing mycobacteria. |
Rossi GG, Guterres KB, Moreira KS, Burgo TAL, de Campos MMA, Iglesias BA |
Photodiagnosis Photodyn Ther |
10.1016/j.pdpdt.2021.102514 |
2021 |
* |
|
Peripheral tetra-cationic Pt(II) porphyrins photo-inactivating rapidly growing mycobacteria: First application in mycobacteriology. |
Rossi GG, Guterres KB, da Silveira CH, Moreira KS, Burgo TAL, Iglesias BA, de Campos MMA |
Microb Pathog |
10.1016/j.micpath.2020.104455 |
2020 |
* |
|
Clinical Mycobacterium abscessus strain inhibits autophagy flux and promotes its growth in murine macrophages. |
Kim SW, Subhadra B, Whang J, Back YW, Bae HS, Kim HJ, Choi CH |
Pathog Dis |
10.1093/femspd/ftx107 |
2017 |
* |
|
galK-based suicide vector mediated allelic exchange in Mycobacterium abscessus. |
Gregoire SA, Byam J, Pavelka MS |
Microbiology (Reading) |
10.1099/mic.0.000528 |
2017 |
* |
|
Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. |
Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile JF, Daffe M, Perronne C, Soudais C, Gaillard JL, Rottman M |
Infect Immun |
10.1128/IAI.00835-06 |
2006 |
* |
|
- References
-
#11592 |
Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ;
DSM 44196
|
-
-
-
-
#24966 |
E. K. Tortoli, Thomas A.,Brown-Elliott, Barbara A.,Trovato, Alberto,Leão, Sylvia Cardoso,Garcia, Maria Jesus,Vasireddy, Sruthi,Turenne, Christine Y.,Griffith, David E.,Philley, Julie V.,Baldan, Rossella,Campana, Silvia,Cariani, Lisa,Colombo, Carla,Taccetti, Giovanni,Teri, Antonio,Niemann, Stefan,Wallace Jr., Richard J.,Cirillo, Daniela M.:
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov.
IJSEM 66:
4471 - 4479
2016 (
DOI 10.1099/ijsem.0.001376 , PubMed 27499141 )
|
-
#37180 |
; Curators of the CIP;
|
-
-
#67770 |
Japan Collection of Microorganism (JCM) ; Curators of the JCM;
|
-
#68379 |
Automatically annotated from API Coryne .
|
-
#68382 |
Automatically annotated from API zym .
|
-
#69479 |
João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.:
MicrobeAtlas 1.0 beta
.
|
-
-
-
#77815 |
Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.:
StrainInfo: A central database for resolving microbial strain identifiers
.
(
DOI 10.60712/SI-ID92877.1 )
|
-
#115980 |
Collection of Institut Pasteur ; Curators of the CIP;
CIP 104536
|
- * These data were automatically processed and therefore are not curated
Change proposal
Successfully sent
|